Modafinil: Preclinical, Clinical, and Post-Marketing Surveillance—A Review of Abuse Liability Issues
HUGH MYRICK M.DROBERT MALCOLM M.D
BRENT TAYLOR
STEVEN LaROWE Ph.D
pages: 101 - 109
- DOI: 10.1080/10401230490453743
- Version of record first published: 2004
Full Text